Cargando…

The global, regional, and national early-onset colorectal cancer burden and trends from 1990 to 2019: results from the Global Burden of Disease Study 2019

PURPOSE: The incidence of early-onset colorectal cancer (EO-CRC), which occurs in people under age 50, has been increasing annually. The aim of this study was to provide an up-to-date estimate of the global EO-CRC burden. METHODS: We used Global Burden of Disease Study data and methodologies to desc...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Hongfeng, Zhao, Zeyi, Deng, Yu, Zheng, Zhifang, Huang, Ying, Huang, Shenghui, Chi, Pan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9555189/
https://www.ncbi.nlm.nih.gov/pubmed/36221047
http://dx.doi.org/10.1186/s12889-022-14274-7
_version_ 1784806853809537024
author Pan, Hongfeng
Zhao, Zeyi
Deng, Yu
Zheng, Zhifang
Huang, Ying
Huang, Shenghui
Chi, Pan
author_facet Pan, Hongfeng
Zhao, Zeyi
Deng, Yu
Zheng, Zhifang
Huang, Ying
Huang, Shenghui
Chi, Pan
author_sort Pan, Hongfeng
collection PubMed
description PURPOSE: The incidence of early-onset colorectal cancer (EO-CRC), which occurs in people under age 50, has been increasing annually. The aim of this study was to provide an up-to-date estimate of the global EO-CRC burden. METHODS: We used Global Burden of Disease Study data and methodologies to describe changes in the EO-CRC burden from 1990 to 2019, including incidence, prevalence, mortality, and disability-adjusted life years (DALYs). The driving factors for cancer burden variation were further analyzed using decomposition analysis. Frontier analysis was used to visually demonstrate the potential for burden reduction in each country or region based on their development levels. RESULTS: The global EO-CRC incidence more than doubled, increasing from 95,737 (95% uncertainty interval (UI): 90,838–101.042) /100,000 in 1990 to 226,782 (95% UI: 207,495–248,604) /100,000 in 2019. Additionally, related deaths increased from 50,997 (95% UI: 47,692–54,410) /100,000 to 87,014 (95% UI: 80,259–94,339) /100,000, and DALYs increased from 256,1842 (95% UI: 239,4962–2,735,823) /100,000 to 4,297,573 (95% UI: 3,965,485–4,650,790) /100,000. Regarding age-standardized rates, incidence and prevalence increased significantly, while mortality and DALYs rate were basically unchanged. Decomposition analysis showed a significant increase in DALYs in the middle sociodemographic index (SDI) quintile region, in which aging and population growth played a major driving role. Frontier analysis showed that countries or regions with a higher SDI quintile tend to have greater improvement potential. CONCLUSION: The current EO-CRC burden was found to be the greatest in the high-middle SDI quintile region and East Asia, which may need to adjust screening guidelines accordingly and introduce more effective interventions. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-022-14274-7.
format Online
Article
Text
id pubmed-9555189
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-95551892022-10-13 The global, regional, and national early-onset colorectal cancer burden and trends from 1990 to 2019: results from the Global Burden of Disease Study 2019 Pan, Hongfeng Zhao, Zeyi Deng, Yu Zheng, Zhifang Huang, Ying Huang, Shenghui Chi, Pan BMC Public Health Research PURPOSE: The incidence of early-onset colorectal cancer (EO-CRC), which occurs in people under age 50, has been increasing annually. The aim of this study was to provide an up-to-date estimate of the global EO-CRC burden. METHODS: We used Global Burden of Disease Study data and methodologies to describe changes in the EO-CRC burden from 1990 to 2019, including incidence, prevalence, mortality, and disability-adjusted life years (DALYs). The driving factors for cancer burden variation were further analyzed using decomposition analysis. Frontier analysis was used to visually demonstrate the potential for burden reduction in each country or region based on their development levels. RESULTS: The global EO-CRC incidence more than doubled, increasing from 95,737 (95% uncertainty interval (UI): 90,838–101.042) /100,000 in 1990 to 226,782 (95% UI: 207,495–248,604) /100,000 in 2019. Additionally, related deaths increased from 50,997 (95% UI: 47,692–54,410) /100,000 to 87,014 (95% UI: 80,259–94,339) /100,000, and DALYs increased from 256,1842 (95% UI: 239,4962–2,735,823) /100,000 to 4,297,573 (95% UI: 3,965,485–4,650,790) /100,000. Regarding age-standardized rates, incidence and prevalence increased significantly, while mortality and DALYs rate were basically unchanged. Decomposition analysis showed a significant increase in DALYs in the middle sociodemographic index (SDI) quintile region, in which aging and population growth played a major driving role. Frontier analysis showed that countries or regions with a higher SDI quintile tend to have greater improvement potential. CONCLUSION: The current EO-CRC burden was found to be the greatest in the high-middle SDI quintile region and East Asia, which may need to adjust screening guidelines accordingly and introduce more effective interventions. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-022-14274-7. BioMed Central 2022-10-12 /pmc/articles/PMC9555189/ /pubmed/36221047 http://dx.doi.org/10.1186/s12889-022-14274-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Pan, Hongfeng
Zhao, Zeyi
Deng, Yu
Zheng, Zhifang
Huang, Ying
Huang, Shenghui
Chi, Pan
The global, regional, and national early-onset colorectal cancer burden and trends from 1990 to 2019: results from the Global Burden of Disease Study 2019
title The global, regional, and national early-onset colorectal cancer burden and trends from 1990 to 2019: results from the Global Burden of Disease Study 2019
title_full The global, regional, and national early-onset colorectal cancer burden and trends from 1990 to 2019: results from the Global Burden of Disease Study 2019
title_fullStr The global, regional, and national early-onset colorectal cancer burden and trends from 1990 to 2019: results from the Global Burden of Disease Study 2019
title_full_unstemmed The global, regional, and national early-onset colorectal cancer burden and trends from 1990 to 2019: results from the Global Burden of Disease Study 2019
title_short The global, regional, and national early-onset colorectal cancer burden and trends from 1990 to 2019: results from the Global Burden of Disease Study 2019
title_sort global, regional, and national early-onset colorectal cancer burden and trends from 1990 to 2019: results from the global burden of disease study 2019
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9555189/
https://www.ncbi.nlm.nih.gov/pubmed/36221047
http://dx.doi.org/10.1186/s12889-022-14274-7
work_keys_str_mv AT panhongfeng theglobalregionalandnationalearlyonsetcolorectalcancerburdenandtrendsfrom1990to2019resultsfromtheglobalburdenofdiseasestudy2019
AT zhaozeyi theglobalregionalandnationalearlyonsetcolorectalcancerburdenandtrendsfrom1990to2019resultsfromtheglobalburdenofdiseasestudy2019
AT dengyu theglobalregionalandnationalearlyonsetcolorectalcancerburdenandtrendsfrom1990to2019resultsfromtheglobalburdenofdiseasestudy2019
AT zhengzhifang theglobalregionalandnationalearlyonsetcolorectalcancerburdenandtrendsfrom1990to2019resultsfromtheglobalburdenofdiseasestudy2019
AT huangying theglobalregionalandnationalearlyonsetcolorectalcancerburdenandtrendsfrom1990to2019resultsfromtheglobalburdenofdiseasestudy2019
AT huangshenghui theglobalregionalandnationalearlyonsetcolorectalcancerburdenandtrendsfrom1990to2019resultsfromtheglobalburdenofdiseasestudy2019
AT chipan theglobalregionalandnationalearlyonsetcolorectalcancerburdenandtrendsfrom1990to2019resultsfromtheglobalburdenofdiseasestudy2019
AT panhongfeng globalregionalandnationalearlyonsetcolorectalcancerburdenandtrendsfrom1990to2019resultsfromtheglobalburdenofdiseasestudy2019
AT zhaozeyi globalregionalandnationalearlyonsetcolorectalcancerburdenandtrendsfrom1990to2019resultsfromtheglobalburdenofdiseasestudy2019
AT dengyu globalregionalandnationalearlyonsetcolorectalcancerburdenandtrendsfrom1990to2019resultsfromtheglobalburdenofdiseasestudy2019
AT zhengzhifang globalregionalandnationalearlyonsetcolorectalcancerburdenandtrendsfrom1990to2019resultsfromtheglobalburdenofdiseasestudy2019
AT huangying globalregionalandnationalearlyonsetcolorectalcancerburdenandtrendsfrom1990to2019resultsfromtheglobalburdenofdiseasestudy2019
AT huangshenghui globalregionalandnationalearlyonsetcolorectalcancerburdenandtrendsfrom1990to2019resultsfromtheglobalburdenofdiseasestudy2019
AT chipan globalregionalandnationalearlyonsetcolorectalcancerburdenandtrendsfrom1990to2019resultsfromtheglobalburdenofdiseasestudy2019